Lumexa Imaging Holdings, Inc. Common Stock (LMRI) - Net Assets
Based on the latest financial reports, Lumexa Imaging Holdings, Inc. Common Stock (LMRI) has net assets worth $599.62 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.76 Billion) and total liabilities ($1.16 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore LMRI asset base for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $599.62 Million |
| % of Total Assets | 34.0% |
| Annual Growth Rate | 71.8% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 92.82 |
Lumexa Imaging Holdings, Inc. Common Stock - Net Assets Trend (2023–2025)
This chart illustrates how Lumexa Imaging Holdings, Inc. Common Stock's net assets have evolved over time, based on quarterly financial data. Check how tangible is Lumexa Imaging Holdings, Inc. Common Sto's equity to evaluate the tangible quality of the company's equity base.
Annual Net Assets for Lumexa Imaging Holdings, Inc. Common Stock (2023–2025)
The table below shows the annual net assets of Lumexa Imaging Holdings, Inc. Common Stock from 2023 to 2025. For live valuation and market cap data, see how much is Lumexa Imaging Holdings, Inc. Common Sto worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $586.12 Million | +188.16% |
| 2024-12-31 | $203.41 Million | +2.51% |
| 2023-12-31 | $198.43 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Lumexa Imaging Holdings, Inc. Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 14120300000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $96.00K | 0.02% |
| Other Components | $1.22 Billion | 207.65% |
| Total Equity | $586.12 Million | 100.00% |
Lumexa Imaging Holdings, Inc. Common Stock Competitors by Market Cap
The table below lists competitors of Lumexa Imaging Holdings, Inc. Common Stock ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Alvotech
IC:ALVO
|
$1.07 Billion |
|
Jintuo Technology Co Ltd
SHG:603211
|
$1.07 Billion |
|
Kingsignal Technology Co Ltd
SHE:300252
|
$1.07 Billion |
|
Fuda Alloy Materials Co Ltd
SHG:603045
|
$1.07 Billion |
|
Jiangsu Rongtai Industry Co. Ltd.
SHG:605133
|
$1.07 Billion |
|
Tompkins Financial Corporation
NYSE MKT:TMP
|
$1.07 Billion |
|
Nanjing Xinjiekou Department Store Co Ltd
SHG:600682
|
$1.07 Billion |
|
No Va Land Investment Group Corp
VN:NVL
|
$1.07 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Lumexa Imaging Holdings, Inc. Common Stock's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 161,654,000 to 586,123,000, a change of 424,469,000 (262.6%).
- Net loss of 47,104,000 reduced equity.
- New share issuances of 435,585,000 increased equity.
- Other factors increased equity by 35,988,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-47.10 Million | -8.04% |
| Share Issuances | $435.58 Million | +74.32% |
| Other Changes | $35.99 Million | +6.14% |
| Total Change | $- | 262.58% |
Book Value vs Market Value Analysis
This analysis compares Lumexa Imaging Holdings, Inc. Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.35x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 5.30x to 1.35x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2023-12-31 | $2.10 | $11.13 | x |
| 2024-12-31 | $1.71 | $11.13 | x |
| 2025-12-31 | $8.26 | $11.13 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Lumexa Imaging Holdings, Inc. Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -8.04%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -4.60%
- • Asset Turnover: 0.58x
- • Equity Multiplier: 3.01x
- Recent ROE (-8.04%) is above the historical average (-42.61%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2023 | -61.60% | -13.06% | 0.56x | 8.42x | $-142.07 Million |
| 2024 | -58.21% | -9.92% | 0.55x | 10.59x | $-110.26 Million |
| 2025 | -8.04% | -4.60% | 0.58x | 3.01x | $-105.72 Million |
Industry Comparison
This section compares Lumexa Imaging Holdings, Inc. Common Stock's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $675,722,059
- Average return on equity (ROE) among peers: -83.90%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI) | $599.62 Million | -61.60% | 1.94x | $1.07 Billion |
| Abbott Laboratories (ABT) | $4.40 Billion | 38.41% | 1.14x | $173.31 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $19.91 Million | -270.00% | 1.43x | $9.82 Million |
| Aethlon Medical Inc (AEMD) | $15.06 Million | -79.86% | 0.16x | $802.22K |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $903.35K |
| Adapthealth Corp (AHCO) | $2.16 Billion | 3.21% | 1.42x | $1.39 Billion |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $456.18K | -277.12% | 2.12x | $5.67 Million |
| Allurion Technologies, Inc. (ALUR) | $-70.49 Million | 0.00% | 0.00x | $13.77 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $7.63 Million | -202.23% | 0.23x | $2.33 Million |
| Artivion Inc (AORT) | $101.44 Million | 9.04% | 0.27x | $1.16 Billion |
| Apyx Medical Inc (APYX) | $2.02 Million | 20.16% | 0.93x | $172.52 Million |
About Lumexa Imaging Holdings, Inc. Common Stock
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was foun… Read more